Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:treprostinil
|
| gptkbp:administeredBy |
improving exercise capacity in PAH patients
|
| gptkbp:approvalYear |
2013
|
| gptkbp:ATCCode |
B01AC21
|
| gptkbp:chemicalClass |
prostanoid
|
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Orenitram
|
| gptkbp:indication |
pulmonary arterial hypertension
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:United_Therapeutics
|
| gptkbp:mechanismOfAction |
prostacyclin analogue
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache flushing jaw pain |
| gptkbp:bfsParent |
gptkb:United_Therapeutics
|
| gptkbp:bfsLayer |
7
|